% Other Income 34.18 22.08 12.10 54.82% Selling & Administrative Expenses 50.96 48.95 2.00 4.11% Finance Cost 18.67 17.57 1.10 6.26% EBT 113.06 24.58 88.47 359.93% Income Tax (22.17) (4.34) 17.83 410.78

) (109) 27 -25% (75) (75) 0 0% Finance cost - Interest expenses (11) (11) 0 0% (7) (8) 1 -13% Corporate income tax 3 (8) 11 -143% 6 (7) 13 -176% Earnings (Loss) for the Period 19 (50) 69 -138% (6) (30) 24

expenses 807.04 123.36 802.63 116.78 Profit (loss) before income tax 29.43 133.92 30.24 136.46 Income tax (7.60) (27.69) (6.65) (27.08) Profit (loss) for the period 21.83 106.24 23.59 109.37 1. The

) before income tax income (0.59) 7.30 (108.08) Income tax income 1.31 1.10 19.09 Profit for the period 0.72 8.39 (91.42) The operating results of the Company and its subsidiaries changed over 20%. In the

% Finance costs (0.06) (0.10) (0.04) 67.00% Profit before income tax expense 2.38 7.65 5.26 220.74% Income tax expense (0.46) (1.20) (0.75) 163.65% Profit for the period 1.93 6.45 4.52 234.22% Other

follows : 1. Income from medical treatments in the consolidated financial Statement went up 6.42% due to income from Chiang Mai Ram Medical Business Plc.”CMR”, a subsidiary amount Baht 3,935.33 million went

% Administrative expenses (26.21) (39.92) (13.71) 52.31% Share of profit of investments in associate 0.09 0.13 0.04 46.78% Finance costs (0.26) (0.34) (0.07) 28.01% Profit before income tax expense 86.37 113.36

associate 0.03 (0.17) (0.21) -642.50% Finance costs (0.06) (0.06) (0.00) 1.40% Profit before income tax expense 24.98 2.38 (22.60) -90.46% Income tax (3.75) (0.46) 3.30 -87.87% Profit for the period 21.23

tax (27.84) 35.53 (21.45) 42.38 Income tax 4.16 (8.31) 4.15 (8.42) Profit (loss) for the period (23.68) 27.22 (17.30) 33.96 1. The Consolidated and the separated statements present the amount of

securities. This is in line with the decrease of the SET Index as a result of the 2019 Coronavirus (COVID-19) outbreak. 3. Income tax expense in this quarter decrease from the same period of last year in the